Paper31375685
Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease.
Siew JJ and 11 others. Nat Commun, 2019. Cited by 198 papers, by iCite.
Cite this record
ConductScience Library. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease. Papers, record 31375685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31375685
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Galectin 3 | Major topic |
| Huntington Disease | Major topic |
| Microglia | Major topic |
| Adult | |
| Animals | |
| Blood Proteins | |
| Disease Models, Animal | |
| Disease Progression | |
| Female | |
| Galectins | |
| Gene Knockdown Techniques | |
| Humans | |
| Inflammasomes | |
| Lysosomes | |
| Male | |
| Mice | |
| Microscopy, Electron, Transmission | |
| Middle Aged | |
| Severity of Illness Index | |
| Up-Regulation |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1202204 | "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. | J Psychiatr Res | 1975 | https://conductscience.org/library/papers/1202204 | PubMed |
| 2 | 23254930 | NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. | Nature | 2013 | https://conductscience.org/library/papers/23254930 | PubMed |
| 3 | 28238188 | Microglia activation and phagocytosis: relationship with aging and cognitive impairment in the rhesus monkey. | Geroscience | 2017 | https://conductscience.org/library/papers/28238188 | PubMed |
| 4 | 19942704 | Decreased diffusivity in the caudate nucleus of presymptomatic huntington disease gene carriers: which explanation? | AJNR Am J Neuroradiol | 2010 | https://conductscience.org/library/papers/19942704 | PubMed |
| 5 | 8684382 | Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. | Mov Disord | 1996 | https://conductscience.org/library/papers/8684382 | PubMed |
| 6 | 25753426 | Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. | Cell Rep | 2015 | https://conductscience.org/library/papers/25753426 | PubMed |
| 7 | 22442086 | Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity. | J Neurosci | 2012 | https://conductscience.org/library/papers/22442086 | PubMed |
| 8 | 23376047 | Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials. | Neurosci Biobehav Rev | 2013 | https://conductscience.org/library/papers/23376047 | PubMed |
| 9 | 22453877 | Age-at-onset in Huntington disease. | PLoS Curr | 2011 | https://conductscience.org/library/papers/22453877 | PubMed |
| 10 | 16365166 | Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. | J Cell Biol | 2005 | https://conductscience.org/library/papers/16365166 | PubMed |
| 11 | 15630413 | Galectins as modulators of tumour progression. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/15630413 | PubMed |
| 12 | 25123926 | Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment? | Mov Disord | 2014 | https://conductscience.org/library/papers/25123926 | PubMed |
| 13 | 11724777 | Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11724777 | PubMed |
| 14 | 20174443 | Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease. | PLoS One | 2010 | https://conductscience.org/library/papers/20174443 | PubMed |
| 15 | 16393961 | Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. | J Immunol | 2006 | https://conductscience.org/library/papers/16393961 | PubMed |
| 16 | 20190189 | GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death. | Blood | 2010 | https://conductscience.org/library/papers/20190189 | PubMed |
| 17 | 23768628 | Huntington's disease: underlying molecular mechanisms and emerging concepts. | Trends Biochem Sci | 2013 | https://conductscience.org/library/papers/23768628 | PubMed |
| 18 | 27170638 | NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx. | Am J Physiol Cell Physiol | 2016 | https://conductscience.org/library/papers/27170638 | PubMed |
| 19 | 25186741 | An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. | J Neurosci | 2014 | https://conductscience.org/library/papers/25186741 | PubMed |
| 20 | 21601164 | Development of biomarkers for Huntington's disease. | Lancet Neurol | 2011 | https://conductscience.org/library/papers/21601164 | PubMed |
Cited by135
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 198 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42914142 | Protective role of Galectin-3 in prion disease through regulation of microglial PrPSc uptake. | Brain Pathol | 2026 | https://conductscience.org/library/papers/42914142 | PubMed |
| 42913222 | Fiber-2 induces autolysosome dysfunction and impairs autophagic flux to promote FAdV-4 replication. | Poult Sci | 2026 | https://conductscience.org/library/papers/42913222 | PubMed |
| 42856177 | DHA deficiency drives neural oxidized-lipid stress and microglial activation. | bioRxiv | 2026 | https://conductscience.org/library/papers/42856177 | PubMed |
| 42620891 | Astrocytes mobilize a broader repertoire of lysosomal repair mechanisms than neurons. | iScience | 2026 | https://conductscience.org/library/papers/42620891 | PubMed |
| 42266582 | Predictive value of Galectin-3 in cognitive impairment: a systematic review and meta-analysis. | Front Neurol | 2026 | https://conductscience.org/library/papers/42266582 | PubMed |
| 42249483 | Microglial galectin-3 disrupts parvalbumin interneurons and hippocampal synchrony, driving cognitive deficits. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/42249483 | PubMed |
| 42215790 | The C9orf72/SMCR8 complex maintains microglial homeostasis via RAB8A-ESCRT-mediated lysosomal repair. | EMBO J | 2026 | https://conductscience.org/library/papers/42215790 | PubMed |
| 42214129 | Modeling stimulus-induced stress responses in microglia-like cells using a commercial iPSC-dCas9-KRAB line. | Stem Cell Res | 2026 | https://conductscience.org/library/papers/42214129 | PubMed |
| 42123328 | Neurotrophins and Galectin-3: Hidden Keys in Neuroinflammation-A Narrative Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123328 | PubMed |
| 41919495 | Lysosomal homeostasis at the crossroads of neurodegeneration. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41919495 | PubMed |
| 41872424 | The utility of aqueous and serum apolipoprotein E and galectin-3 as biomarkers of neuroinflammation in glaucoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/41872424 | PubMed |
| 41772384 | Berbamine hydrochloride as a brain-penetrant galectin-3 inhibitor in a model of Huntington's disease. | Brain | 2026 | https://conductscience.org/library/papers/41772384 | PubMed |
| 41750302 | Galectins: Role and Therapeutics in Diabetes and Diabetic Foot Ulcers. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750302 | PubMed |
| 41701549 | Galectin-3 mediates lysosome-related inflammation within monocyte-derived macrophages in a mouse model of ischemic brain injury. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41701549 | PubMed |
| 41484627 | Organelle stress in NLRP3 inflammasome: a central mediator of neurodegenerative diseases. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/41484627 | PubMed |
| 41483050 | Programmed cell death pathways in huntington's disease: spotlight on ferroptosis and pyroptosis. | Neurol Sci | 2026 | https://conductscience.org/library/papers/41483050 | PubMed |
| 41453865 | Unlocking microglia pyroptosis in a model of type I interferon-driven neuroinflammation: lessons from Rnaset2-/- mice. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41453865 | PubMed |
| 41387458 | Identification of a reactive astrocyte subpopulation during HIV-associated pain pathogenesis in mouse models. | Nat Commun | 2025 | https://conductscience.org/library/papers/41387458 | PubMed |
| 41280719 | Targeting inflammasome pathway towards therapeutics of neurodegenerative diseases. | Organelle | 2025 | https://conductscience.org/library/papers/41280719 | PubMed |
| 41240184 | Neuroprotective Effects of Glucosamine in Huntington's Disease Through NLRP3 Inflammasome Inhibition. | J Neuroimmune Pharmacol | 2025 | https://conductscience.org/library/papers/41240184 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31375685
GET https://conductscience.org/api/papers/v1/31375685/references?page=2